The FDA has cleared the first-ever smartphone app developed by Tandem Diabetes Care to program insulin dosage for its t:slim X2 insulin pump users.
People with diabetes will have an easier time getting insulin into their bodies with just one tap on their phone. The Food and Drug Administration has cleared the first-ever smartphone app developed by Tandem Diabetes Care to program insulin dosage for its t:slim X2 insulin pump users.
John Sheridan, president and CEO of Tandem Diabetes Care, said in a statement that the insulin delivery app is one of the most requested features from the diabetes community, and the FDA clearance validated the company’s commitment to innovating diabetes management tools for people who need more efficient ways of keeping their blood glucose levels in check. With to the update, pump users can program or cancel their bolus doses, which they normally have to take during mealtimes.
The bolus dose delivery app may prove useful to people who are already uncomfortable with having their pumps out in public settings like restaurants or sticking them to undergarments. The t:connect app already shows users their blood sugar patterns and insulin dosage history, as well as any alarms and alerts they may have missed, so the updated app gives them the opportunity to administer insulin doses as discreetly as possible.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA Recalls 3 Powdered Infant Formulas Manufactured At Abbott Michigan PlantThe Food and Drug Administration said it is investigating four reports of infants who were hospitalized after consuming the formula, including one who died.
Lire la suite »
FDA warns against some baby formulas after complaints of contaminationThe Food and Drug Administration announced Thursday that it is investigating certain powdered infant formula following four customer reports of children contracting serious infections.
Lire la suite »
FDA warns against some baby formulas after customer complaints of contaminationThe U.S. Food and Drug Administration is cautioning parents and caregivers after recent reports of infections and one death.
Lire la suite »
FDA investigates possible Salmonella infections from powdered infant formulaThe Food and Drug Administration said the health agency is recommending consumers stop using certain powdered infant formula products from Similac, Alimentum and EleCare while the agency investigates further.
Lire la suite »
FDA warns recalled baby formula can cause serious illnessesBacteria linked to the formula may have played a role in the sickening of four infants and may have contributed to a death in one case.
Lire la suite »
FDA Warns Consumers Not to Use Select Abbott Baby Formula After Risk of ContaminationFour babies have fallen ill so far, prompting a product recall.
Lire la suite »